Genetic Predisposition to Cardiovascular Disease in Patients With Cancer: A Clinical Perspective

por Farmakis, Dimitrios, Papingiotis, Georgios, Filippatos, Gerasimos
Publicado 2023

Cancer and Takotsubo syndrome: from rarity to clinical practice

por Keramida, Kalliopi, Farmakis, Dimitrios, Filippatos, Gerasimos
Publicado 2021

Drug therapy for patients with systolic heart failure after the PARADIGM-HF trial: in need of a new paradigm of LCZ696 implementation in clinical practice

por Filippatos, Gerasimos, Farmakis, Dimitrios, Parissis, John, Lekakis, John
Publicado 2015

Differential effects of inotropes and inodilators on renal function in acute cardiac care

por Zima, Endre, Farmakis, Dimitrios, Pollesello, Piero, Parissis, John T
Publicado 2020

Inflammation and Heart Failure: Searching for the Enemy—Reaching the Entelechy

por Paraskevaidis, Ioannis, Farmakis, Dimitrios, Papingiotis, Georgios, Tsougos, Elias
Publicado 2023

Cardioprotective Agents for the Primary Prevention of Trastuzumab-Associated Cardiotoxicity: A Systematic Review and Meta-Analysis

por Goulas, Kyriakos, Farmakis, Dimitrios, Constantinidou, Anastasia, Kadoglou, Nikolaos P. E.
Publicado 2023

Clinical effects of cardiac contractility modulation in heart failure with mildly reduced systolic function

por Tschöpe, Carsten, Butler, Javed, Farmakis, Dimitrios, Morley, Deborah, Rao, Ishu, Filippatos, Gerasimos
Publicado 2020

Contemporary Role of Cardiac Magnetic Resonance in the Management of Patients with Suspected or Known Coronary Artery Disease

por Bazoukis, George, Papadatos, Stamatis S., Michelongona, Archontoula, Lampropoulos, Konstantinos, Farmakis, Dimitrios, Vassiliou, Vassilis
Publicado 2021

Levosimendan in Europe and China: An Appraisal of Evidence and Context

por Kong, Xiangqing, Hu, Xinqun, Hua, Baotong, Fedele, Francesco, Farmakis, Dimitrios, Pollesello, Piero
Publicado 2021

Heart Failure 2013

por Giamouzis, Gregory, Triposkiadis, Filippos, Georgiopoulou, Vasiliki V., Farmakis, Dimitrios, Westermann, Dirk, Skoularigis, John
Publicado 2013

2021 Thalassaemia International Federation Guidelines for the Management of Transfusion-dependent Thalassemia

por Farmakis, Dimitrios, Porter, John, Taher, Ali, Domenica Cappellini, Maria, Angastiniotis, Michael, Eleftheriou, Androulla
Publicado 2022

Impact of SGLT2 inhibitors on major clinical events and safety outcomes in heart failure patients: a meta-analysis of randomized clinical trials

por Bazoukis, George, Papadatos, Stamatis S., Thomopoulos, Costas, Tse, Gary, Cheilidis, Stefanos, Tsioufis, Konstantinos, Farmakis, Dimitrios
Publicado 2021

Anticoagulation for atrial fibrillation in active cancer

por Farmakis, Dimitrios, Papakotoulas, Pavlos, Angelopoulou, Eleni, Bischiniotis, Theodoros, Giannakoulas, George, Kliridis, Panagiotis, Richter, Dimitrios, Paraskevaidis, Ioannis
Publicado 2022

Diabetes Mellitus and Heart Failure

por Triposkiadis, Filippos, Xanthopoulos, Andrew, Bargiota, Alexandra, Kitai, Takeshi, Katsiki, Niki, Farmakis, Dimitrios, Skoularigis, John, Starling, Randall C., Iliodromitis, Efstathios
Publicado 2021

Effects of empagliflozin on cardiovascular and renal outcomes in heart failure with reduced ejection fraction according to age: a secondary analysis of EMPEROR‐Reduced

por Filippatos, Gerasimos, Anker, Stefan D., Butler, Javed, Farmakis, Dimitrios, Ferreira, João Pedro, Gollop, Nicholas D., Brueckmann, Martina, Iwata, Tomoko, Pocock, Stuart, Zannad, Faiez, Packer, Milton
Publicado 2022

Pharmaceutical Prevention and Management of Cardiotoxicity in Hematological Malignancies

por Perpinia, Anastasia Stella, Kadoglou, Nikolaos, Vardaka, Maria, Gkortzolidis, Georgios, Karavidas, Apostolos, Marinakis, Theodoros, Papachrysostomou, Chrysostomi, Makaronis, Panagiotis, Vlachou, Charikleia, Mantzourani, Marina, Farmakis, Dimitrios, Konstantopoulos, Konstantinos
Publicado 2022

Churg–Strauss syndrome‐associated heart failure and left ventricular thrombosis

por Liori, Sotiria, Samiotis, Eleftherios, Birba, Dionysia, Katsimbri, Pelagia, Mademli, Maria, Bakola, Eleni, Tsivgoulis, Georgios, Quris, Estela, Bonios, Michael, Kalabaliki, Maria, Farmakis, Dimitrios, Parissis, John, Frogoudaki, Alexandra
Publicado 2023

Protocol update and preliminary results of EACVI/HFA Cardiac Oncology Toxicity (COT) Registry of the European Society of Cardiology

por Lancellotti, Patrizio, Galderisi, Maurizio, Donal, Erwan, Edvardsen, Thor, Popescu, Bogdan A., Farmakis, Dimitrios, Filippatos, Gerasimos, Habib, Gilbert, Lestuzzi, Chiara, Santoro, Ciro, Moonen, Marie, Jerusalem, Guy, Andarala, Maryna, Anker, Stefan D.
Publicado 2017

Finerenone in patients with chronic kidney disease and type 2 diabetes with and without heart failure: a prespecified subgroup analysis of the FIDELIO‐DKD trial

por Filippatos, Gerasimos, Pitt, Bertram, Agarwal, Rajiv, Farmakis, Dimitrios, Ruilope, Luis M., Rossing, Peter, Bauersachs, Johann, Mentz, Robert J., Kolkhof, Peter, Scott, Charlie, Joseph, Amer, Bakris, George L., Anker, Stefan D.
Publicado 2022

Serelaxin in acute heart failure patients with preserved left ventricular ejection fraction: results from the RELAX-AHF trial

por Filippatos, Gerasimos, Teerlink, John R., Farmakis, Dimitrios, Cotter, Gad, Davison, Beth A., Felker, G. Michael, Greenberg, Barry H., Hua, Tsushung, Ponikowski, Piotr, Severin, Thomas, Unemori, Elaine, Voors, Adriaan A., Metra, Marco
Publicado 2014